Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad. (Q39426084)

11 September 2017

title

Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad. (English)

1 reference

11 September 2017

0 references

1 reference

ChEBI release 2020-05-28

7

1 reference

11 September 2017

Shutao Yin

1

1 reference

11 September 2017

Yinhui Dong

2

1 reference

11 September 2017

Jinghua Li

3

1 reference

11 September 2017

Lihong Fan

4

1 reference

11 September 2017

Lei Wang

5

1 reference

11 September 2017

Junxuan Lu

6

1 reference

11 September 2017

Hongbo Hu

8

1 reference

11 September 2017

publication date

1 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

17

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

388-399

1 reference

Dysregulation of apoptosis in cancer

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Bcl-2 inhibitors: small molecules with a big impact on cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Targeting multiple arms of the apoptotic regulatory machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

RNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

A prospective study of plasma selenium levels and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

ARC synergizes with ABT-737 to induce apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Cellular survival: a play in three Akts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Induction of Noxa sensitizes human colorectal cancer cells expressing Mcl-1 to the small-molecule Bcl-2/Bcl-xL inhibitor, ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Evaluation of potential Stat3-regulated genes in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

The BH3 mimetic ABT-737 induces cancer cell senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Interleukin-6 in bone metastasis and cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0687-9

10.1007/S10495-011-0687-9

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference